What happened
Federal Trade Commission Chairman Andrew N. Ferguson has directed agency staff to form a Healthcare Task Force aimed at coordinating the FTC's healthcare enforcement and advocacy work across competition, consumer protection, economics, policy and technology offices.
The FTC said the task force will lead targeted enforcement and advocacy initiatives, devise agencywide investigation strategies, identify amicus and statement-of-interest opportunities, and look for emerging enforcement and advocacy priorities. The move gives the agency a named internal structure for healthcare work that can span merger review, anticompetitive conduct, consumer protection and policy advocacy.
The agency said the task force will seek to expand its membership to include other agencies and law enforcement partners, including the U.S. Department of Health and Human Services and the U.S. Department of Justice. That planned outreach points to a broader enforcement posture in a sector where competition questions often overlap with consumer protection, reimbursement, technology and public-health policy.
The FTC cast the move as the latest step in its efforts to create a more competitive, innovative, affordable and higher quality healthcare system, citing President Trump's executive order. The press release did not include the full memorandum Ferguson issued to staff, leaving the task force's leadership, internal deadlines and specific enforcement priorities to be confirmed from the underlying document.
In the press release, the FTC pointed to recent healthcare-related actions including an Express Scripts settlement, a challenge to Edwards' proposed JenaValve acquisition, the abandonment of the Alcon-Lensar merger, health insurance-related consumer redress and action against substance-abuse treatment facilities. For competition lawyers, the immediate significance is not a new rule or court holding, but a signal that healthcare matters may receive more coordinated attention across FTC units and, potentially, with DOJ and HHS.